Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pelvic Neoplasms × Radiotherapy × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 51 Prostatic Neoplasms 41 Carcinoma, Non-Small-Cell Lung 34 Lung Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 32 Lymphoma 30 Head and Neck Neoplasms 28 Leukemia 19 Brain Neoplasms 19 Central Nervous System Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Glioblastoma 16 Esophageal Squamous Cell Carcinoma 16 Esophageal Neoplasms 16 Uterine Cervical Neoplasms 15 Rectal Neoplasms 15 Sarcoma 14 Lymphoma, Follicular 14 Burkitt Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 12 Hodgkin Disease 12 Oligodendroglioma 11 Lymphoma, Non-Hodgkin 11 Neoplasm Metastasis 10 Astrocytoma 10 Adenocarcinoma of Lung 10 Nasopharyngeal Carcinoma 9 Lymphoma, Large-Cell, Immunoblastic 9 Rhabdomyosarcoma 8 Lymphoma, B-Cell, Marginal Zone 8

Interventions

Gemcitabine 2 liposomal doxorubicin 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy 1 Pafolacianine 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06651697 2026-02-17

BEFORE

University of California, San Diego

Phase 3 Recruiting

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡